Rare diseases
Investigational molecules
Locations
Study on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
FranceStudy of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment
FranceStudy of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments
FranceStudy on Ustekinumab and Guselkumab for Children with Active Juvenile Psoriatic Arthritis
FranceStudy on ANV600 and Pembrolizumab for Patients with Advanced Solid Tumors
FranceStudy of Debio 4228 for Patients with Advanced or Metastatic Prostate Cancer
FranceStudy of Resmetirom in Patients with Well-compensated Non-alcoholic Steatohepatitis (NASH) Cirrhosis to Evaluate Effects on Liver Health
FranceStudy Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer
FranceStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
FranceStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
FranceStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
FranceStudy on Pausing Treatment with Pembrolizumab and Axitinib in Patients with Metastatic Kidney Cancer at Good or Intermediate Risk
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
